Replies to post #57811 on Biotech Values

[y3maxx]

""Is KG really cutting's its bovine thrombin price by 30% for multi year contracts? What I heard before was a 10-15% reduction in price.
Kevin DeGeeter, an analyst at Oppenheimer & Co., said, there were signs that King Pharmaceuticals was aggressively cutting the price of its product.""

imo,,,,Hospitals should interpret the above as a big, big, big red flag against KG bovine thrombin.

[xrymd]

My hospital as of last Thursday pays $66/vial for Bovine thrombin. It was $17 a vial in 1999 so I guess King got as much as they could in the last few years. Those multi year contracts may slow the uptake of Recothrom as most users wouldn't even know the difference in each product. They (ZGEN) should IMO match the price cuts. Sell it at $70. My hospital would likely bite for only a $4 difference.